Brady Stewart Biography and Net Worth

Director of Evolus

Brady Stewart has served as a member of our board of directors since January 2022. Mrs. Stewart has served as the Chief Commercial Officer of Forma Brands, LLC since April 2021. From May 2007 to April 2021, Mrs. Stewart held multiple roles at Levi Strauss & Co., culminating in the position of Senior Vice President and Managing Director, U.S. Direct to Consumer. Mrs. Stewart holds an M.B.A in Strategy and Operations from Harvard Business School and received a Bachelor’s degree in Comparative Literature from Princeton University.

What is Brady Stewart's net worth?: The estimated net worth of Brady Stewart is at least $503.86 thousand as of August 15th, 2025. Stewart owns 88,629 shares of Evolus stock worth more than $503,856 as of May 4th. This net worth estimate does not reflect any other investments that Stewart may own. Learn More about Brady Stewart's net worth.
How do I contact Brady Stewart?: The corporate mailing address for Stewart and other Evolus executives is 520 Newport Center Dr. Suite 1200, Newport Beach CA, 92660. Evolus can also be reached via phone at (949) 284-4555 and via email at [email protected]. Learn More on Brady Stewart's contact information.
Has Brady Stewart been buying or selling shares of Evolus?: Brady Stewart has not been actively trading shares of Evolus during the last quarter. Most recently, on Friday, August 15th, Brady Stewart bought 30,000 shares of Evolus stock. The stock was acquired at an average cost of $6.82 per share, with a total value of $204,600.00. Following the completion of the transaction, the director now directly owns 88,629 shares of the company's stock, valued at $604,449.78. Learn More on Brady Stewart's trading history.
Who are Evolus' active insiders?: Evolus' insider roster includes Rui Avelar (Insider), David Gill (Director), David Gill (Director), Vikram Malik (Director), David Moatazedi (Insider), Brady Stewart (Director), Albert White, III (Director), and Tomoko Yamagishi-Dressler (CMO). Learn More on Evolus' active insiders.
Are insiders buying or selling shares of Evolus?: During the last twelve months, Evolus insiders bought shares 2 times. They purchased a total of 50,000 shares worth more than $393,600.00. During the last twelve months, insiders at the sold shares 12 times. They sold a total of 335,597 shares worth more than $2,468,766.11. The most recent insider tranaction occured on March, 20th when insider Rui Avelar sold 3,119 shares worth more than $14,815.25. Insiders at Evolus own 6.1% of the company. Learn More about insider trades at Evolus.
Information on this page was last updated on 3/20/2026.

Brady Stewart Insider Trading History at Evolus

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/15/2025	Buy	30,000	$6.82	$204,600.00	88,629

Brady Stewart Buying and Selling Activity at Evolus

Evolus Company Overview

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Today's Range

Now: $5.58

$5.26

$5.75

50 Day Range

MA: $4.68

$3.94

$5.66

2 Week Range

Now: $5.58

$3.86

$12.24

Volume

1,986,699 shs

Average Volume

1,165,202 shs

Market Capitalization

$363.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28